Home » Results From Phase IIa Retigabine Study Inconclusive
Results From Phase IIa Retigabine Study Inconclusive
Valeant Pharmaceuticals International announced Monday [that] preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia, a painful and common complication of shingles.
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May